NEXN and atherosclerosis: Atorvastatin decreases expression of NLRP3, caspase1, GSDMD and inflammatory factors (IL-1β and IL-18) via the lncRNA nexilin F-actin binding protein antisense RNA 1 (NEXN-AS1)/NEXN pathway to inhibit human vascular endothelial cell pyroptosis, reversing atherosclerosis [56].